Clinical Depression: Signs, Symptoms, Treatments for Depression

Conditions We Treat

Clinical Depression

Depression is not sadness. It is a neurobiological condition that changes how your brain functions — and it responds to precise, targeted treatment.

TGA Approved — MBS 14217

Treatment-resistant depression is the primary TGA-approved indication for rTMS in Australia. Medicare rebates apply under MBS 14216 (calibration) and MBS 14217 (treatment). A gap between the rebate and our fee may be covered by private health insurance, DVA, TAC, WorkCover, or CTP.

Understanding the condition

What is clinical depression?

Depression is not a mood state. It is a neurobiological condition in which specific brain circuits — particularly those governing emotional regulation, motivation, and cognitive function — become dysregulated in ways that persistently disrupt daily life.

The experience varies between individuals. Some people describe it as sadness or hopelessness. Others describe emotional numbness — an inability to feel anything at all. Others experience it primarily as physical exhaustion, cognitive slowing, or an inability to engage with work, relationships, or activities they once found meaningful.

What these presentations share is duration, severity, and functional impact. Clinical depression is not a response to a difficult circumstance that resolves when the circumstance changes. It is a condition with identifiable neural mechanisms that requires — and responds to — clinical treatment.

Symptoms may include

Persistent low mood, emptiness, or emotional numbness lasting more than two weeks

Loss of interest or pleasure in previously enjoyable activities

Fatigue, disrupted sleep, and changes in appetite or weight

Cognitive difficulties — concentration, decision-making, word-finding

Withdrawal from social contact and relationships

Persistent negative thought patterns, hopelessness, or thoughts of self-harm

Recognition

When to seek professional assessment

Professional assessment is indicated when symptoms persist for two weeks or more, interfere with daily functioning, or do not resolve with rest, social support, or lifestyle changes. You do not need to be in crisis to seek help — earlier assessment leads to earlier, more effective intervention.

01 You have been feeling emotionally flat for two weeks or more

Duration is a key clinical marker. A persistent low that does not lift distinguishes clinical depression from ordinary mood fluctuation.

02 You have lost interest in activities that previously mattered to you

Anhedonia — the inability to experience pleasure — is one of the core features of clinical depression and one of the most reliable indicators that something more than sadness is occurring.

03 Your functioning at work, home, or in relationships is significantly affected

When depression begins to compromise your ability to work, maintain relationships, or carry out daily tasks, clinical assessment is important.

04 Medication or previous treatment has not produced adequate relief

If you have tried one or more antidepressants without achieving full remission, alternative or adjunct options — including rTMS — are clinically indicated and worth discussing.

A more complex presentation

Treatment-resistant depression

Treatment-resistant depression (TRD) is defined clinically as a failure to achieve adequate remission following two or more antidepressant trials at therapeutic doses for sufficient duration. Approximately one in three people with major depressive disorder fall into this category.

For patients with TRD, the evidence for a further antidepressant trial is not strong. Each failed trial reduces the probability of response to the next. This is where rTMS becomes clinically significant — it operates on a fundamentally different mechanism to medication, targeting the brain’s electrical architecture directly rather than its chemical systems.

High-frequency rTMS to the left dorsolateral prefrontal cortex (DLPFC) is the TGA-approved protocol for treatment-resistant depression in Australia, with response rates of approximately 50–60% in patients who have not responded to medication.

Symptoms may include

Two or more failed antidepressant trials

At adequate doses, for adequate duration, without sufficient response.

Partial response that does not achieve remission

Some improvement with medication but persistent residual symptoms that affect daily functioning.

Medication intolerance

Side effects that make sustained pharmacological treatment impractical — a different treatment pathway is clinically appropriate.

rTMS is TGA-approved for treatment-resistant depression and Medicare-listed under MBS 14216 and MBS 14217. A gap applies between the Medicare rebate and our fee.

Our approach

How Brain Aid Clinics treats depression

Every patient at Brain Aid Clinics undergoes a thorough clinical assessment before treatment begins. Treatment is never prescribed in advance of understanding your specific presentation.

01 Psychiatry-led assessment

A thorough clinical review of your history, previous treatments, current presentation, and goals. This determines whether rTMS is appropriate and what protocol is indicated for your brain.

02 MRI-guided neuronavigation

Your individual brain anatomy is mapped using your MRI before treatment begins. The coil is tracked in real time every session — ensuring stimulation reaches the intended cortical target, not an estimate of it.

03 The TMF Programmeme

Thought, Movement, and Food. A structured clinical programme integrated into every course of treatment — because the evidence is clear that neuroplasticity, cortisol regulation, and inflammation all influence how well your brain responds to stimulation.

Common Questions

What patients ask us

What does depression actually feel like?

Depression presents differently between individuals. Many people describe persistent emptiness or numbness rather than sadness — an inability to feel engaged or interested in anything, even things that previously mattered. Others experience it as a pervasive heaviness, cognitive slowing, or an exhaustion that sleep does not resolve. Some experience primarily physical symptoms: unexplained pain, appetite changes, or disrupted sleep. What unifies these presentations is their persistence, their impact on daily functioning, and their resistance to ordinary efforts to improve mood.

Why do I feel numb rather than sad?

Emotional numbness is a common presentation of depression and reflects disruption to the brain’s emotional processing circuits rather than the absence of a problem. When the prefrontal and limbic systems are dysregulated, the ability to experience both positive and negative emotions can be blunted. Many patients describe this as more distressing than sadness — the absence of feeling is itself a significant symptom and warrants clinical assessment.

Can depression happen without an obvious reason?

A referral from a GP or psychiatrist is required for Medicare-funded rTMS. If you’d prefer to speak with us first to learn more, you’re very welcome — our team caYes. Depression has neurobiological underpinnings — genetic predisposition, brain chemistry, and circuit-level function all contribute. External circumstances can precipitate or worsen an episode, but they are not required to. Many people experience depression when life appears objectively fine, and this can compound feelings of confusion or shame. The absence of a clear external trigger does not make the condition less real or less treatable. n support you in obtaining a referral if needed.

What is treatment-resistant depression and am I experiencing it?

Treatment-resistant depression is clinically defined as a failure to achieve adequate remission following two or more antidepressant trials at therapeutic doses for sufficient duration. If you have tried medication and it hasn’t worked — whether because of inadequate response, partial response only, or intolerable side effects — a clinical assessment is worthwhile. rTMS is TGA-approved specifically for this population and offers a different mechanism to medication, not simply more of the same approach.

What treatment options are available for depression?

Evidence-based options include psychological therapies (CBT, ACT, IPT), antidepressant medication, and rTMS. These can be used individually or in combination. rTMS is specifically indicated for patients who have not achieved adequate remission with medication and operates via a different mechanism — direct modulation of brain circuit activity rather than systemic pharmacological effects. At Brain Aid Clinics, treatment is always preceded by a thorough clinical assessment and designed around your specific presentation.

Can lifestyle changes help with depression?

Yes, and the mechanisms are well understood. Regular physical activity upregulates BDNF — a key driver of neuroplasticity. Dietary quality influences neuroinflammation and neurotransmitter production. Sleep architecture affects emotional regulation and memory consolidation. These are not peripheral wellness additions — they are direct inputs into the brain systems that depression disrupts. At Brain Aid Clinics, the TMF Programmeme (Thought, Movement, Food) formalises these factors as a structured clinical component of every treatment course, not an optional extra.

Is rTMS covered by Medicare?

Yes. Medicare rebates are available for rTMS for treatment-resistant depression under MBS 14216 (calibration) and MBS 14217 (treatment), where treatment is initiated under a psychiatrist management plan. A gap applies between the Medicare rebate and our fee. This gap may be covered by private health insurance (BUPA, Medibank), DVA Gold Card, TAC, WorkCover, or CTP depending on your circumstances. Our team can help you clarify your entitlements before you book.

How is depression diagnosed?

Diagnosis is made through a comprehensive clinical assessment by a qualified health professional, using recognised criteria (DSM-5 or ICD-11) and considering your individual history and circumstances. This includes a detailed review of your symptoms, their duration, their impact on daily functioning, and any relevant medical or psychological history. Standardised screening tools may be used to support the assessment. Diagnosis always considers your unique circumstances.

How can I support someone with depression?

The most useful support is often consistent, non-judgemental presence. Avoid minimising what they’re experiencing or suggesting they should be able to improve how they feel through willpower. Encourage professional assessment when they’re ready, and help practically where you can — accompanying them to an appointment, helping them research options. Withdrawal and irritability are symptoms of the condition, not rejections of you. Your own wellbeing matters too — supporting someone with depression can be demanding, and accessing your own support is appropriate.

What should I expect at my first appointment at Brain Aid Clinics? +

Your first appointment is a clinical assessment, not a treatment session. Your treating clinician will review your history in detail — previous diagnoses, medications trialled, current presentation, and what you’re hoping to achieve. Your eligibility for rTMS is confirmed, any contraindications are assessed, and you receive a clear explanation of the protocol and realistic expectations for your individual presentation. You leave with a clear picture of whether rTMS is appropriate and what a course of treatment would involve — before you commit to anything.

Clinical and regulatory note: rTMS is TGA-approved and Medicare-listed (MBS 14217) for treatment-resistant depression only. All information on this page is for general informational purposes and does not constitute medical advice. Please consult a qualified health professional regarding your individual circumstances. Brain Aid Clinics provides all care within AHPRA-compliant clinical and regulatory boundaries with full informed consent at every stage. ABN 76 664 676 420.

Conditions We Treat